Abdera Therapeutics is a biopharmaceutical company that provides an antibody engineering platform to design and develop precision radiopharmaceuticals for cancer. Its radio-optimized vector engineering (ROVEr) platform integrates drug discovery and antibody engineering technologies to selectively destroy tumor cells and enable the development of therapies serving cancer patients.